vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $70.6M, roughly 1.3× MEDALLION FINANCIAL CORP). Vericel Corp runs the higher net margin — 25.0% vs 17.3%, a 7.7% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs 23.3%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 15.0%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
MFIN vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $92.9M |
| Net Profit | $12.2M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 29.3% | 24.1% |
| Net Margin | 17.3% | 25.0% |
| Revenue YoY | 25.4% | 23.3% |
| Net Profit YoY | 20.3% | 17.3% |
| EPS (diluted) | $0.50 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $92.9M | ||
| Q3 25 | $58.7M | $67.5M | ||
| Q2 25 | $62.6M | $63.2M | ||
| Q1 25 | $63.0M | $52.6M | ||
| Q4 24 | $56.3M | $75.4M | ||
| Q3 24 | $53.3M | $57.9M | ||
| Q2 24 | $51.0M | $52.7M | ||
| Q1 24 | $53.3M | $51.3M |
| Q4 25 | $12.2M | $23.2M | ||
| Q3 25 | $7.8M | $5.1M | ||
| Q2 25 | $11.1M | $-553.0K | ||
| Q1 25 | $12.0M | $-11.2M | ||
| Q4 24 | $10.1M | $19.8M | ||
| Q3 24 | $8.6M | $-901.0K | ||
| Q2 24 | $7.1M | $-4.7M | ||
| Q1 24 | $10.0M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 29.3% | 24.1% | ||
| Q3 25 | 33.2% | 5.1% | ||
| Q2 25 | 31.1% | -3.2% | ||
| Q1 25 | 32.1% | -24.3% | ||
| Q4 24 | 32.8% | 24.5% | ||
| Q3 24 | 26.6% | -4.3% | ||
| Q2 24 | 24.3% | -11.5% | ||
| Q1 24 | 33.6% | -10.7% |
| Q4 25 | 17.3% | 25.0% | ||
| Q3 25 | 13.2% | 7.5% | ||
| Q2 25 | 17.7% | -0.9% | ||
| Q1 25 | 19.1% | -21.4% | ||
| Q4 24 | 18.0% | 26.3% | ||
| Q3 24 | 16.1% | -1.6% | ||
| Q2 24 | 13.9% | -8.9% | ||
| Q1 24 | 18.8% | -7.5% |
| Q4 25 | $0.50 | $0.46 | ||
| Q3 25 | $0.32 | $0.10 | ||
| Q2 25 | $0.46 | $-0.01 | ||
| Q1 25 | $0.50 | $-0.23 | ||
| Q4 24 | $0.43 | $0.40 | ||
| Q3 24 | $0.37 | $-0.02 | ||
| Q2 24 | $0.30 | $-0.10 | ||
| Q1 24 | $0.42 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $137.5M |
| Total DebtLower is stronger | $216.0M | — |
| Stockholders' EquityBook value | $408.6M | $354.6M |
| Total Assets | $3.0B | $488.0M |
| Debt / EquityLower = less leverage | 0.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $137.5M | ||
| Q3 25 | $72.5M | $135.4M | ||
| Q2 25 | $110.4M | $116.9M | ||
| Q1 25 | $131.5M | $112.9M | ||
| Q4 24 | $98.2M | $116.2M | ||
| Q3 24 | $120.6M | $101.7M | ||
| Q2 24 | $87.7M | $102.5M | ||
| Q1 24 | $54.8M | $110.6M |
| Q4 25 | $216.0M | — | ||
| Q3 25 | $215.7M | — | ||
| Q2 25 | $199.9M | — | ||
| Q1 25 | $199.7M | — | ||
| Q4 24 | $232.2M | — | ||
| Q3 24 | $232.0M | — | ||
| Q2 24 | $230.8M | — | ||
| Q1 24 | $225.6M | — |
| Q4 25 | $408.6M | $354.6M | ||
| Q3 25 | $397.4M | $321.9M | ||
| Q2 25 | $389.9M | $306.8M | ||
| Q1 25 | $380.2M | $295.5M | ||
| Q4 24 | $370.2M | $292.0M | ||
| Q3 24 | $362.4M | $257.5M | ||
| Q2 24 | $354.0M | $243.0M | ||
| Q1 24 | $349.0M | $233.9M |
| Q4 25 | $3.0B | $488.0M | ||
| Q3 25 | $2.9B | $453.3M | ||
| Q2 25 | $2.9B | $435.6M | ||
| Q1 25 | $2.8B | $424.6M | ||
| Q4 24 | $2.9B | $432.7M | ||
| Q3 24 | $2.9B | $390.4M | ||
| Q2 24 | $2.8B | $376.8M | ||
| Q1 24 | $2.6B | $356.7M |
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.63× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 10.35× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $15.0M | ||
| Q3 25 | $67.0M | $22.1M | ||
| Q2 25 | $-10.7M | $8.2M | ||
| Q1 25 | $36.3M | $6.6M | ||
| Q4 24 | $108.7M | $22.2M | ||
| Q3 24 | $24.6M | $10.2M | ||
| Q2 24 | $27.6M | $18.5M | ||
| Q1 24 | $32.3M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | — | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | 10.35× | 0.65× | ||
| Q3 25 | 8.63× | 4.35× | ||
| Q2 25 | -0.97× | — | ||
| Q1 25 | 3.02× | — | ||
| Q4 24 | 10.72× | 1.12× | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFIN
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
